Carglumic acid is used in the management of rare, life-threatening inborn metabolic disorders affecting the urea cycle. Dipharma S.A., a Swiss pharmaceutical company specialized in developing ...
Nutrameltz, a Canadian health and wellness company, will soon introduce fast-dissolving tablets to more than 70 percent of American adults who take dietary supplements. PALM BEACH, FL, March 16, 2021 ...
This review article discusses orally disintegrating tablets and their manufacturing technologies, development issues, and future trends. These tablets are distinguished from conventional sublingual ...
Nutrameltz, a Canadian health and wellness company, will soon introduce fast-dissolving tablets to more than 70 percent of American adults who take dietary supplements. PALM BEACH, FL, Feb. 02, 2021 ...
Adding to its store of technology weapons, Catalent Pharma can now offer fast-dissolve tablet technology to clients. It obtained the development rights to Lyopan from Pantec. The lyophilized tablets ...
SOMERSET, NJ, February 15, 2011 - Catalent Pharma Solutions, the world's leading provider of advanced oral drug delivery technologies and solutions, announced that it has entered into a license ...
Researchers at Akina Inc. are developing Purdue University-licensed technologies that improve the ways in which prescription drugs, over-the-counter medicines and even vitamins are administered orally ...
Aprecia's Spritam tablets, quickly dissolvable in liquid--Courtesy of Aprecia The FDA on Monday approved Aprecia Pharmaceuticals' Spritam, which is the first 3-D printed product designed for use in ...
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced it recently entered into an ...
The Extra Strength Tylenol “Rapid Release gels” package depicts a blue-and-red capsule gushing a cloud of pain-relieving medicine from laser-drilled holes, a visual depiction of relief. But the gels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results